You are here

  • Home
  • Archive
  • Volume 31, Issue 12
  • ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian …

Article metrics

Article menu

Download PDFPDF

Clinical trial
ATHENA (GOG-3020/ENGOT-ov45): a randomized, phase III trial to evaluate rucaparib as monotherapy (ATHENA–MONO) and rucaparib in combination with nivolumab (ATHENA–COMBO) as maintenance treatment following frontline platinum-based chemotherapy in ovarian cancer

 

Online download statistics by month:

Online download statistics by month: September 2021 to April 2024

AbstractFullPdf
Sep 2021626312
Oct 2021605573243
Nov 2021316314102
Dec 2021520517109
Jan 202229229172
Feb 2022301306105
Mar 2022319334110
Apr 2022364380135
May 2022305312164
Jun 2022368367166
Jul 202221422193
Aug 2022261240106
Sep 2022263258122
Oct 2022260274133
Nov 2022208200110
Dec 202211311145
Jan 202315114756
Feb 2023202188109
Mar 2023153149102
Apr 202317116383
May 202311911462
Jun 202314013064
Jul 202311811162
Aug 202312411847
Sep 202313012260
Oct 202312612656
Nov 202318117766
Dec 202317617163
Jan 202422221783
Feb 202416915498
Mar 2024185179143
Apr 202411110271
Total724971293052